Analytical Data
-
Gene name
MYOD1
- Application
-
Alternative Names
bHLHc1; Class C basic helix-loop-helix protein 1; MYF 3; Myf-3; MYF3; Myoblast determination protein 1; Myod 1; MYOD; MYOD1; MYOD1_HUMAN; Myogenic differentiation 1; Myogenic factor 3; Myogenic factor MYF 3; Myogenin D1; PUM
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P15172
-
Expression Region
1-320 aa
-
AA Sequence
MELLSPPLRD VDLTAPDGSL CSFATTDDFY DDPCFDSPDL RFFEDLDPRL MHVGALLKPE EHSHFPAAVH PAPGAREDEH VRAPSGHHQA GRCLLWACKA CKRKTTNADR RKAATMRERR RLSKVNEAFE TLKRCTSSNP NQRLPKVEIL RNAIRYIEGL QALLRDQDAA PPGAAAAFYA PGPLPPGRGG EHYSGDSDAS SPRSNCSDGM MDYSGPPSGA RRRNCYEGAY YNEAPSEPRP GKSAAVSSLD CLSSIVERIS TESPAAPALL LADVPSESPP RRQEAAAPSE GESSGDPTQS PDAAPQCPAG ANPNPIYQVL
-
Molecular Weight
34.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYOD1, a member of the myogenic regulatory factor family, plays a crucial role in muscle development and differentiation. Its primary function is to regulate the myogenic lineage by promoting the expression of genes essential for muscle cell formation. Abnormalities in MYOD1 expression and function have been implicated in various muscle-related disorders, including muscle atrophy and certain types of cancer, such as rhabdomyosarcoma. Research on MYOD1 recombinant proteins has gained significant attention because these proteins can serve as vital tools for understanding the mechanisms of myogenesis and muscle regeneration. By producing recombinant MYOD1, scientists can investigate its interactions with other myogenic proteins, delineate the signaling pathways involved in muscle differentiation, and identify potential therapeutic targets for muscle degenerative diseases. Additionally, the structural and functional characterization of MYOD1 through recombinant technology provides insights into its role in gene transcription and muscle cell identity. Understanding MYOD1 at a molecular level is essential for developing innovative strategies to combat muscle-wasting conditions and enhance regenerative medicine applications. Consequently, MYOD1 recombinant protein research is pivotal in uncovering the complexities of muscle biology and advancing clinical approaches to muscle repair and restoration.
